Rational Protein Design Yields a CD20 CAR with Superior Antitumor Efficacy Compared with CD19 CAR.
Chen X, Chen LC, Khericha M, Meng X, Salvestrini E, Shafer A, Iyer N, Alag AS, Ding Y, Nicolaou DM, Chen YY.
Chen X, et al. Among authors: chen yy, chen lc.
Cancer Immunol Res. 2023 Feb 3;11(2):150-163. doi: 10.1158/2326-6066.CIR-22-0504.
Cancer Immunol Res. 2023.
PMID: 36409926
Free PMC article.